Predict your next investment

HEALTHCARE | Drug Development
elcelyx.com

See what CB Insights has to offer

Stage

Debt | Dead

Total Raised

$90.34M

Last Raised

$480K

About Elcelyx Therapeutics

Elcelyx Therapeutics is developing therapeutic agents based on the finding that modulation of the neuro-enteroendocrine system of the gut, including L-cells, amplifies the release of hormones such as those that play an important role in glucose regulation. This discovery affords a potentially safety advantaged platform to develop therapies as well as re-position existing therapies to meet serious unmet needs. Elcelyx's Metformin Delayed Release (Metformin DR) releases metformin in the gut instead of systemically, reducing bioavailability while still achieving efficacy. In two previous Phase 2 studies, Metformin DR lowered glucose and was well tolerated in patients with type 2 diabetes.

Elcelyx Therapeutics Headquarter Location

11975 El Camino Real Suite 305

San Diego, California, 92130,

United States

858-876-1814

Latest Elcelyx Therapeutics News

Elcelyx Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250

Oct 6, 2018

Summary Elcelyx Therapeutics Inc Elcelyx is a developer of novel therapies for the treatment of type 2 diabetes and other unmet medical needs. The company develops pharmaceutical agents that are designed to modulate the gut neuroendocrine system including the Lcell. Its products include Metformin DR, a delayedrelease formulation of metformin that is designed to release metformin primarily in the distal small intestine and restrict metformin to the bowel. The company's Metformin DR is used in glucose lowering for type 2 diabetes patients with renal impairment. Elcelyx is headquartered in San Diego, California, the US. Elcelyx Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Elcelyx Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Elcelyx Therapeutics is included in 2 Expert Collections, including Omics.

O

Omics

274 items

D

Diabetes

1,750 items

Elcelyx Therapeutics Patents

Elcelyx Therapeutics has filed 18 patents.

The 3 most popular patent topics include:

  • Diabetes
  • G protein coupled receptors
  • Piperidines
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/17/2018

6/2/2020

Diabetes, Piperidines, Piperazines, G protein coupled receptors, Muscarinic antagonists

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

7/17/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

6/2/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Diabetes, Piperidines, Piperazines, G protein coupled receptors, Muscarinic antagonists

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.